StockSelector.com
  Research, Select, & Monitor Saturday, August 18, 2018 12:25:28 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Arrowhead Pharmaceuticals, Inc.$14.51$.181.26%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Arrowhead Pharmaceuticals, Inc. has an overall rank of 6541 out of 7022 stocks based on 6 positive rankings and 9 negative rankings.

Positive Rankings
Historic Revenue Growth
Arrowhead Pharmaceuticals rank is 16
90 Day Gain
Arrowhead Pharmaceuticals rank is 107
Target Prices
The average analysts' target price is $17.00 for Arrowhead Pharmaceuticals using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Arrowhead Pharmaceuticals is ranked 467.
Debt-to-Equity
Arrowhead Pharmaceuticals rank is 630
Highest Cash Growth
Arrowhead Pharmaceuticals rank is 1466
Up EPS Surprise
Arrowhead Pharmaceuticals beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
Price-to-Sales
Arrowhead Pharmaceuticals rank is 118
Negative Net Margin
Arrowhead Pharmaceuticals rank is 273
Price-to-Book
Arrowhead Pharmaceuticals rank is 308
High Put/Call
Arrowhead Pharmaceuticals has a high Put/Call ratio of 0.98 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Arrowhead Pharmaceuticals is ranked 397.
High vPut/Call
Arrowhead Pharmaceuticals has a high Put/Call ratio of 0.96 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Arrowhead Pharmaceuticals is ranked 478.
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Arrowhead Pharmaceuticals is ranked 554.
Negative ROE
Arrowhead Pharmaceuticals rank is 665
Negative ROA
Arrowhead Pharmaceuticals rank is 692
10 Day Loss
Arrowhead Pharmaceuticals rank is 2033







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.